{"id":"https://openalex.org/W79965724","doi":"https://doi.org/10.1016/s0065-7743(09)04407-8","title":"Chapter 7 The Emergence of GPR119 Agonists as Anti-Diabetic Agents","display_name":"Chapter 7 The Emergence of GPR119 Agonists as Anti-Diabetic Agents","publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W79965724","doi":"https://doi.org/10.1016/s0065-7743(09)04407-8","mag":"79965724"},"language":"en","primary_location":{"id":"doi:10.1016/s0065-7743(09)04407-8","doi":"https://doi.org/10.1016/s0065-7743(09)04407-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0065-7743(09)04407-8","pdf_url":null,"source":{"id":"https://openalex.org/S10038074","display_name":"Annual reports in medicinal chemistry","issn_l":"0065-7743","issn":["0065-7743","1557-8437"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"book series"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annual Reports in Medicinal Chemistry","raw_type":"book-chapter"},"volume":null,"type":"book-chapter","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018079253","display_name":"Robert M. Jones","orcid":"https://orcid.org/0000-0002-8415-5565","observed_orcids":["https://orcid.org/0000-0002-8415-5565"]},"institutions":[{"id":"https://openalex.org/I4210126734","display_name":"Arena Pharmaceuticals (United States)","ror":"https://ror.org/02w3y1050","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126734"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert M. Jones","raw_affiliation_strings":["Arena Pharmaceuticals, 6166 Nancy Ridge Drive, San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arena Pharmaceuticals, 6166 Nancy Ridge Drive, San Diego, CA 92121, USA","institution_ids":["https://openalex.org/I4210126734"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110088494","display_name":"James N. Leonard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126734","display_name":"Arena Pharmaceuticals (United States)","ror":"https://ror.org/02w3y1050","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126734"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James N. Leonard","raw_affiliation_strings":["Arena Pharmaceuticals, 6166 Nancy Ridge Drive, San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arena Pharmaceuticals, 6166 Nancy Ridge Drive, San Diego, CA 92121, USA","institution_ids":["https://openalex.org/I4210126734"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210126734"],"apc_list":null,"apc_paid":null,"fwci":25.9604,"has_fulltext":false,"cited_by_count":40,"citation_normalized_percentile":{"value":0.99430524,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":null,"issue":null,"first_page":"149","last_page":"170"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10839","display_name":"Pancreatic function and diabetes","score":0.01590000092983246,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gpr119-agonists","display_name":"GPR119 agonists","score":0.9800000190734863},{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":0.722000002861023},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.8199999928474426},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.7129999995231628},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.7250000238418579},{"id":"https://openalex.org/keywords/oral-antidiabetic-drugs","display_name":"oral antidiabetic drugs","score":0.6240000128746033},{"id":"https://openalex.org/keywords/intestinal-endocrine-cells","display_name":"intestinal endocrine cells","score":0.8970000147819519},{"id":"https://openalex.org/keywords/glucose-dependent-insulin-secretion","display_name":"glucose-dependent insulin secretion","score":0.847000002861023},{"id":"https://openalex.org/keywords/pancreatic-islets","display_name":"pancreatic islets","score":0.8090000152587891},{"id":"https://openalex.org/keywords/insulinoma-cell-lines","display_name":"insulinoma cell lines","score":0.8640000224113464},{"id":"https://openalex.org/keywords/sirna-knockdown","display_name":"siRNA knockdown","score":0.7590000033378601},{"id":"https://openalex.org/keywords/energy-homeostasis","display_name":"energy homeostasis","score":0.8640000224113464}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5453311204910278},{"id":"https://openalex.org/C2780053029","wikidata":"https://www.wikidata.org/wiki/Q1501239","display_name":"Insulinoma","level":3,"score":0.5302550196647644},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5014755725860596},{"id":"https://openalex.org/C2778563252","wikidata":"https://www.wikidata.org/wiki/Q170617","display_name":"Glucagon","level":3,"score":0.4754740297794342},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.47336360812187195},{"id":"https://openalex.org/C3018667095","wikidata":"https://www.wikidata.org/wiki/Q3455903","display_name":"Glucose homeostasis","level":4,"score":0.46810173988342285},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4175992012023926},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.4111071825027466},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4041493535041809},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3790290653705597},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.35974231362342834},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34997761249542236},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.23912560939788818},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.20366191864013672},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.12382477521896362},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s0065-7743(09)04407-8","doi":"https://doi.org/10.1016/s0065-7743(09)04407-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0065-7743(09)04407-8","pdf_url":null,"source":{"id":"https://openalex.org/S10038074","display_name":"Annual reports in medicinal chemistry","issn_l":"0065-7743","issn":["0065-7743","1557-8437"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"book series"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annual Reports in Medicinal Chemistry","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W1582296909","https://openalex.org/W1979963836","https://openalex.org/W2032322539","https://openalex.org/W2045343006","https://openalex.org/W2048636541","https://openalex.org/W2063388729","https://openalex.org/W2076025331","https://openalex.org/W2078434336","https://openalex.org/W2085802434","https://openalex.org/W2096726403","https://openalex.org/W2097680104","https://openalex.org/W2098889553","https://openalex.org/W2124200900","https://openalex.org/W2152181679","https://openalex.org/W2159205789","https://openalex.org/W2162315539","https://openalex.org/W2171081455","https://openalex.org/W2188846692"],"related_works":["https://openalex.org/W2384765226","https://openalex.org/W3159327416","https://openalex.org/W2005993586","https://openalex.org/W2096726403","https://openalex.org/W1525602924","https://openalex.org/W4322757832","https://openalex.org/W2419329056","https://openalex.org/W2129057259","https://openalex.org/W2105249303","https://openalex.org/W2098889553"],"abstract_inverted_index":null,"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":10}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2016-06-24T00:00:00"}